Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan

Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan

Abstract Purpose Polycystic ovary syndrome (PCOS) significantly affects women. This study investigated the association between serum anti‐Müllerian hormone (AMH) levels and menstrual cycle disorders, and AMH for PCOS in a general cohort of young Japanese women. Methods We measured serum AMH levels i...

Full description

Saved in:
Bibliographic Details
Main Authors: Natsuki Miyake, Satoko Osuka, Isao Ohsawa, Takashi Tonoike, Tomoko Uno, Kazuo Tsuzuki, Bayasula, Reina Sonehara, Ayako Muraoka, Tomoko Nakamura, Maki Goto, Akira Iwase, Hiroaki Kajiyama
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Reproductive Medicine and Biology
Subjects:
anti‐Müllerian hormone
menstrual irregularity
polycystic ovary syndrome
preconception care
puberty
Online Access:https://doi.org/10.1002/rmb2.12615
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Purpose Polycystic ovary syndrome (PCOS) significantly affects women. This study investigated the association between serum anti‐Müllerian hormone (AMH) levels and menstrual cycle disorders, and AMH for PCOS in a general cohort of young Japanese women. Methods We measured serum AMH levels in 528 healthy female students at two universities in Japan between 2014 and 2020. We investigated the association between serum AMH levels and hormone levels, menstrual cycle, and body mass index. Results The mean (±standard deviation) AMH level was 4.78 ± 2.88 ng/mL. Correlations were observed between serum AMH and luteinizing hormone (LH) or LH/follicle‐stimulating hormone (FSH) levels in women with irregular menstruation (LH: r = 0.542, p < 0.001; LH/FSH: r = 0.584, p < 0.001). The optimal serum AMH cutoff value that predicted LH ≥7.1 IU/L and LH/FSH ≥1.21 (PCOS diagnostic criteria revised by Japan Society of Obstetrics and Gynecology) in women with menstrual irregularities was 5.30 ng/mL (area under the curve: 0.815, sensitivity: 84.2%, specificity: 70.3%). Conclusions Serum AMH can be measured during annual health checkups and may be a useful biomarker for early and arcuate diagnosis and intervention in women with PCOS.
ISSN:1445-5781
1447-0578

Similar Items